These results are consistent with other studies that identified an overexpression of COL10A1 in urothelial bladder, breast, colorectal, and pancreatic cancers, associated with tumor progression and poor prognosis [13,14,15,16]. This evidence concerns the gene COL10A1 and pancreatic neoplasm.